A practical reference on thymalfasin: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-06-26. Anything still debated is marked as such rather than presented as settled.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
Stability depends on temperature, pH, and the number of freeze-thaw events the sample has experienced. Freeze-dried material is commonly held at -20 °C or colder, while reconstituted liquid is kept cold and used within a short window. Extreme pH and prolonged light exposure can promote deamidation, oxidation, or aggregation, particularly at asparagine and methionine positions. Adsorption to container walls can lower the measured concentration of a dilute solution even when the peptide molecules themselves remain intact.
| Property | Value | Notes |
|---|---|---|
| Residue count | 28 amino acids | Acetyl group on the first residue |
| Approximate molecular mass | 3108 daltons | Calculated from the consensus sequence |
| Origin | Cleavage product of prothymosin alpha | Not encoded as a separate gene product |
| Primary research focus | Immune modulation | Studied in viral hepatitis and as a vaccine adjuvant |
| Common synonyms | Thymalfasin, Tα1, thymosin alpha 1 | Thymalfasin is the assigned nonproprietary name |
Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.
The peptide occurs naturally in thymic tissue and has been detected in serum and other biological fluids. Reported concentrations are low, and reliable measurement generally requires immunoassay or mass spectrometry with an enrichment step. It is released from a larger precursor, prothymosin alpha, by proteolytic cleavage, although the enzymes involved are not fully characterized. Whether circulating levels reflect thymic output specifically remains an open question.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
=== Physical properties === Technetium is a silvery-gray radioactive metal with an appearance similar to platinum, commonly obtained as a gray powder. The crystal structure of the bulk pure metal is hexagonal close-packed. Atomic technetium has characteristic emission lines at wavelengths of 363.3 nm, 403.1 nm, 426.2 nm, 429.7 nm, and 485.3 nm. The unit cell parameters of the orthorhombic Tc metal were reported when Tc is contaminated with carbon (a = 0.2805(4), b = 0.4958(8), c = 0.4474(5)·nm for Tc-C with 1.38 wt% C and a = 0.2815(4), b = 0.4963(8), c = 0.4482(5)·nm for Tc-C with 1.96 wt% C ). The metal form is slightly paramagnetic, meaning its magnetic dipoles align with external magnetic fields, but will assume random orientations once the field is removed. Pure, metallic, single-crystal technetium becomes a type-II superconductor at temperatures below 7.46 K (−265.69 °C; −446.24 °F). Below this temperature, technetium has a very high magnetic penetration depth, greater than any other element except niobium.
Psychologist Bruno Bettelheim believed that autism was linked to early childhood trauma, and his work was highly influential for decades both in the medical and popular spheres. In his discredited theory, he blamed the mothers of individuals with autism for having caused their child's condition through the withholding of affection. Leo Kanner, who first described autism, suggested that parental coldness might contribute to autism. Although Kanner eventually renounced the theory, Bettelheim put an almost exclusive emphasis on it in both his medical and his popular books. Treatments based on these theories failed to help children with autism, and after Bettelheim's death, his reported rates of cure (around 85%) were found to be fraudulent.
1RAR trained in Kenya from December 1943 to September 1944, when it transferred to Ceylon and became part of the 22nd (East Africa) Infantry Brigade alongside the 1st KAR and the 3rd Northern Rhodesia Regiment. In December 1944, after three months' training for jungle warfare, 1RAR and the other two components of the brigade joined the Burma Campaign at Chittagong under the command of the 15th Indian Corps. The brigade spent about three months supporting the 25th Indian Division in north-western Burma, advancing through the Mayu peninsula during January 1945 and taking part in the latter stages of the Battle of Ramree Island, landing on the island on 14 February. 1RAR fortified positions at Myinbin, Kyaukkale and Mayin but did not contact Japanese forces. A widespread belief developed among Japanese troops in Burma that the British Army's African soldiers were cannibals, partly because of deliberate disinformation spread by the black troops themselves as they travelled around the country. While entirely unfounded, the notion "that we Africans eat people", as one RAR soldier put it, had a fearsome psychological effect; men of 1RAR reported Japanese soldiers picking up their comrades' bodies in the midst of battle and running away. In March 1945 the 22nd Brigade was ordered south to Dalaba where it became part of the 82nd (West Africa) Division, which had been tasked with clearing the Taungup area of Japanese troops.
Sources: en.wikipedia.org
== Pathophysiology == Lipoproteins released from treatment of Treponema pallidum infections are believed to induce the Jarisch–Herxheimer reaction. The Herxheimer reaction has shown an increase in inflammatory cytokines during the period of exacerbation, including tumor necrosis factor alpha, interleukin-6 and interleukin-8.
April 21, 1944: Women are granted the right to vote and to stand for election, by ordinance of the Provisional Government of the French Republic then located in Algiers. April 12, 1945: Ordinance on divorce and legal separation. April 29, 1945: First vote with women participating as voters, during municipal elections. September 1, 1945: Ordinance on paternal correction, notably abolishing the "right to paternal correction." October 4, 1945: Ordinance establishing Social Security; its provisions include the creation of mandatory maternity leave (14 weeks) with compensation amounting to half of the salary. October 9, 1945: Creation of the National School of Administration (ENA), which accepts women, provided they do not seek positions strictly reserved for men. October 19, 1945: Ordinance establishing the French Nationality Code. November 2, 1945: Ordinance on maternal and child protection. April 11, 1946: Law allowing women to access the judiciary. April 13, 1946: Ban on brothels and strengthening the fight against pimping, by the so-called "Marthe Richard law." April 24, 1946: Law establishing a sanitary and social registry of prostitution. May 18, 1946: Law granting an additional leave to heads of household, whether salaried, civil servants, or public service agents, for each birth in their household. July 30, 1946: Order repealing provisions allowing wage reductions for "female wages." August 22, 1946: Law establishing the family benefits system.
===== Cuba ===== On 15 September, Lula and four of his cabinet minister visited Cuba where they met with Cuban president and first secretary of the Communist Party of Cuba Miguel Díaz-Canel. During his visit, Lula also attended a summit of the Group of 77 plus China in Havana where he lamented the United States embargo against Cuba stating that the island "is the victim of an illegal economic embargo, Brazil is against any unilateral coercive measure". Lula also criticized the inclusion of Cuba in the US list of states sponsors of terrorism.
== Function and location == The OXTR protein belongs to the G protein-coupled receptor (GPCR) family, specifically Gq, and acts as a receptor for oxytocin. Its activity is mediated by G proteins that activate several different second messenger systems. Oxytocin receptors are expressed by the myoepithelial cells of the mammary gland, and in both the myometrium and endometrium of the uterus at the end of pregnancy. The oxytocin receptor system plays an important role as an inducer of uterine contractions during parturition and of milk ejection. OXTR is also associated with the central nervous system. The gene is believed to play a major role in social, cognitive, and emotional behavior. A decrease in OXTR expression by methylation of the OXTR gene is associated with callous and unemotional traits in adolescence, rigid thinking in anorexia nervosa, problems with facial and emotional recognition, and difficulties in the affect regulation. A reduction in this gene is believed to lead to prenatal stress, postnatal depression, and social anxiety. Studies on OXTR methylation—which downregulates oxytocin mechanisms—suggest this process is associated with increased gray matter density in the amygdala, implicating OXTR regulation in stress and parasympathetic regulation. Social isolation has been found to decrease oxytocin receptor levels in rodents, whereas levels of oxytocin were unchanged.
Sources: en.wikipedia.org
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.
The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.
Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.
Cold storage slows the chemical degradation reactions that occur in solution. Lyophilized powder is more stable than reconstituted liquid and tolerates longer storage periods. Repeated temperature cycling should still be avoided because it can drive aggregation and loss of material.